Ross Overbeek

Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY.

SMARTRAC TECHNOLOGY Dresden GmbH engages in the design, manufacture, and testing of electronic and electromechanical components, particularly miniaturized components. It specializes in technologies for the production of electronic circuit boards, installation of microassemblies, as well as the development and manufacture of equipment for the production and testing of microasseblies. The company was founded in November 1994 and is headquartered in Dresden, Germany.

DEWB AG (Venture Capital) (DEWB-VC) is the venture capital subsidiary of Deutsche Effecten & Wechsel Beteiligungs AG (FR: EFF), headquartered in Jena, Germany. The firm, established in 1997, provides equity capital, corporate development expertise and network support to strong growth, medium-sized technology companies.

Incuron LLC develops anticancer drugs. It provides an innovative pipeline of drugs to treat oncology and autoimmune disease for the global markets. The firm is a joint venture between Bioprocess Capital Ventures and Cleveland BioLabs. The company was founded in January 2010 and is headquartered in Moscow, Russia.

National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Ergo 2000, Inc. operates as a manufacturing and design company that provides server components in the United States. The company offers rack mount LCD/KVM drawers for server and data monitoring. It also provides product launch services and product maintenance services. The company is headquartered in Fullerton, CA.

GPER G-1 Development Group LLC is a company that has developed a novel therapeutic called G-1 (Tespria) for the treatment of diabetes and obesity. Approximately one third of the population is either diabetic or pre-diabetic, and the estimated economic burden of diabetes in the US in 2017 was over $300 billion. The company is based in Albuquerque, NM. The company aims to target metabolic activity in "brown fat" cells to treat these conditions. G-1 (Tespria) has minimal competition and is revolutionary in that it modulates energy expenditure in the absence of changes in food intake or activity. The company was founded by John J. Chavez, and the CEO is John W. Elling.

Part of Deutsche Effecten & Wechsel Beteiligungs AG, Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt) specializes in private equity fund. The company is based in Jena, Germany.

Eni Rewind produces and markets chemicals. The company is headquartered in Cardano Al Campo, Italy.

Part of Ajinomoto Co., Inc., Orsan is a French company that produces specialty chemicals. The company is based in Paris, France.

The Marine Biological Laboratory provides research and educational services. It offers a range of courses, workshops, conferences, and internships, discovery-based education programs and courses. The firm s a private marine laboratory, supporting scientists and staff working in such fields as cell and developmental biology, ecology, microbiology, molecular evolution, global infectious disease, neurobiology, and sensory physiology. The company was founded in 1888 and is headquartered in Woods Hole, MA.

Torrey Pines Investment, Inc (Torrey Pines Investment) is a venture capital firm is founded in 2002 by Nikolay Savchuk.The firm is headquartered San Diego, California.

Afraxis, Inc. operates as a contract research organization (CRO), specializes in preclinical efficacy evaluations (in vivo and in vitro), neurotoxicity evaluations, and structure-efficacy relationship (SER)-driven medicinal chemistry. It develops Afraxis ESP, an enhanced spine analysis platform that quantifies the morphology and maturity of synaptic dendritic spines, which are fundamental to information processing by neural synapses in the brain. The company was founded by Jay B. Lichter, Carmine Stengone, Susumu Tonegawa and Ben Vollrath in 2007 and is headquartered in San Diego, CA.

ChemDiv, Inc. operates as a discovery and development contract research organization. It specializes in early and clinical development of anti-infectives and antivirals, oncologics, CNS, cardiometabolics, and anti-inflammatory therapies. The firm?s services include synthetic chemistry, structural biology and structure-based drug discovery, molecular modeling, medicinal chemistry, scale-up, biochemical and cellular assay development, analytical/bioanalytical platforms, ADME/tox, DMPK, and multiple in vivo efficacy/tox models. The company was founded by Alexander Ivachtchenko in 1991 and is headquartered in San Diego, CA.

Teal Ventures Management LLC (Teal Ventures) is a venture capital firm founded by Nikolay Savchuk, Ron Demuth, and Eddie Rodriguez in 2018. The firm Headquartered in San Diego, California.

Chromis Therapeutics, Inc. focuses on the development of curative treatments for chronic HBV infection, based on its advanced proprietary drug design and discovery platform. Its CHR101 has a potential to eradicate HBV and to efficiently cure chronically infected HBV patients, as compared to drugs currently on the market. The company was founded by Vadim Bichko and is headquartered in San Diego, CA.

Viriom, Inc. is a biotechnology company based in San Diego, CA. The company focuses on developing innovative therapies for infectious diseases, including HIV and COVID-19. Viriom's mission is to improve the lives of patients by providing effective and accessible treatments. Iain David Dukes has been the CEO of the company since 2019, leading the team in their efforts to advance the development of their pipeline and bring new therapies to market.

Greffen Systems, Inc. provides HVAC industrial solutions. It offers design, project management, installation, testing and ongoing product services. The firm specializes in UV-C germicidal lighting, upper air fixtures, M2G and infection control solution. The company was founded in 2008 and is headquartered in Dawsonville, GA.

Acoustic Cytometry Systems, Inc. manufactures cell-testing devices. It commercializes single molecule sensitivity flow cytometers that enable a new generation of proprietary applications in life science research, clinical diagnostics, and industry. The company's products are used for blood exam and medical research. Acoustic Cytometry Systems was founded by John W. Elling in 2006 and is headquartered in Los Alamos, NM

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

Nanotron Technologies GmbH develops and provides wireless communications systems. The firm’s platform consists of chips, modules, and software that enable real-time positioning and concurrent wireless communication. Its products include swarm, nano location systems (RTLS), and transceiver. The company was founded by Manfred Koslar and Zbigniew Ianelli in 1991 and is headquartered in Berlin, Germany.

LemnaTec GmbH develops research platforms and analysis software for agricultural chemistry, plant cultivation, biotechnology, and pharmacy. It generates reproducible and scientifically sound images in light wavelengths. The firm develops also imaging, image analysis automatisation, and data handling modules. The company was founded by Dirk Vandenhirtz and Matthias Eberius in 1998 and is headquartered in Aachen, Germany.

Part of Deutsche Effecten & Wechsel Beteiligungs AG, DEWB Effecten GmbH operates as an investment holding German company. The company is based in Jena, Germany. The CEO of the company is Bertram Köhler.